Molekule Consulting Inc. Launches New Website, Collateral and Incorporates Wholly-Owned European Subsidiary
Miami, FL, April 23, 2014 --(PR.com
)-- Molekule Consulting Inc. launches new website, collateral and incorporates wholly-owned European subsidiary
Molekule Consulting Inc. refreshes corporate image while concurrently incorporating wholly-owned European subsidiary – to base European headquarters in London, UK
Molekule Consulting Inc. (“Molekule”) today announced the incorporation of a wholly-owned European subsidiary in London, UK. European headquarters for Molekule are based in London, UK – further European Molekule offices are based in Basel, CH, Brussels, BE and Prague, CZ. Molekule’s rest-of-world (“ROW”) physical presence includes Global Headquarters in Miami, USA and offices in key international biopharmaceutical business hubs in Boston, USA, Chicago, USA, New York, USA, San Francisco, USA, São Paulo, BS, Tel Aviv, IL and Tokyo, JP.
Molekule is recognized as a global leader in the development and refinement of primary competitive insights and intelligence for the biopharmaceutical and life sciences industries. Seeking to align intelligence outcomes, focus results and enable client partners the ability to “win” in a highly dynamic and competitive space, Molekule remains a trusted partner of biopharma today and tomorrow.
“I am encouraged by our robust and exponential near-term growth. We have greatly exceeded targeted expectations and I base this on our exceptional consulting staff and internal management. Molekule’s true clinical, therapy area, industry and subject matter expertise affords our firm the ability to provide colorful and granular insights and actionability to our client partners – pharmaceutical, biotechnology and life sciences players – enabling them to win,” said David L. Alderman, President & Managing Director of Molekule Consulting Inc.
About Molekule Consulting Inc.
Molekule Consulting Inc. (“Molekule”) is a global consultancy headquartered in Miami, Florida. We partner with pharmaceutical, biotechnology and medical device companies providing evidence-based solutions and actionable strategic and tactical insights. Molekule also supports other organizations in the biopharmaceutical and life sciences verticals including but not limited to other consultancies, venture capital groups, private equity groups and hedge funds. Leveraging primary research methodologies as the cornerstone of strategic development, Molekule supports the continuum of tactical and strategic decisions for pharmaceutical, biotechnology and medical device clients.
More information about Molekule Consulting Inc. can be found at www.molekuleconsulting.com
Molekule Consulting Inc.
Aligned Intelligence. Focused Results.
Molekule Consulting Inc.
David Alderman, +1 305-504-3030; firstname.lastname@example.org
Brian Curley, +1 508-801-1610; email@example.com